Depomed Eyes More Acquisitions With PDL Royalty Sale Cash
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma plans additional purchases that fit into its growing pain and neurology portfolio, after a late-stage failure in women’s health. With the cash infusion, it may make bigger deals than before.